Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.570
+0.080 (3.21%)
At close: Mar 9, 2026, 4:00 PM EDT
2.523
-0.047 (-1.81%)
After-hours: Mar 9, 2026, 7:49 PM EDT
Annovis Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 68 | 69 | 192 | 110 | 142 | 52 | |
| Market Cap Growth | 56.74% | -63.84% | 75.03% | -23.01% | 174.06% | - | |
| Enterprise Value | 53 | 57 | 186 | 78 | 95 | 43 | |
| Last Close Price | 2.57 | 5.03 | 18.70 | 13.43 | 17.58 | 7.54 | |
| PB Ratio | 3.94 | 7.46 | -24.76 | 3.87 | 3.20 | 6.89 | |
| P/TBV Ratio | 5.18 | 7.46 | - | 3.87 | 3.20 | 6.89 | |
| Net Debt / Equity Ratio | -1.16 | -1.13 | 0.74 | -1.00 | -1.03 | -1.07 | |
| Quick Ratio | 4.09 | 2.72 | 1.35 | 3.69 | 30.33 | 13.96 | |
| Current Ratio | 4.60 | 3.59 | 2.39 | 4.68 | 30.54 | 14.04 | |
| Return on Equity (ROE) | -246.14% | -3159.09% | -546.40% | -69.57% | -55.68% | -180.82% | |
| Return on Assets (ROA) | -105.88% | -138.26% | -121.77% | -38.88% | -33.58% | -89.86% | |
| Return on Capital Employed (ROCE) | -198.60% | -265.80% | -759.60% | -90.10% | -32.70% | -88.10% | |
| Earnings Yield | -36.53% | -35.43% | -29.29% | -23.10% | -10.17% | -10.51% | |
| Buyback Yield / Dilution | -61.36% | -35.60% | -10.55% | -7.03% | -20.88% | -2132.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.